Showing results (201-210 of 242) with videos related to
Sort By:
Pageof 25
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 5, 2024
Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group StudyUtku Akgör, Derman Basaran, Mehmet Mutlu Meydanli, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 27, 2016
Extrauterine Spread, Adjuvant Treatment, and Prognosis in Noninvasive Uterine Papillary Serous Carcinoma of the Endometrium: A Retrospective Multicenter StudyGokhan Boyraz, Mehmet Coskun Salman, Derman Basaran, et al.Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|October 27, 2021
The safety of major gynaecologic cancer surgery without routine preoperative COVID-19 testing in the COVID-19 era: a multicentre, retrospective, case-control studyMurat Oz, Mehmet Mutlu Meydanli, Mufide Iclal Altintas, et al.Turkish Journal of Medical Sciences|July 20, 2020
COVID-19 experience of the major pandemic response center in the capital: results of the pandemic’s first month in TurkeyRahmet Güner, İmran Hasanoğlu, Bircan Kayaaslan, et al.Journal of Surgical Oncology|March 3, 2021
Impact of cytoreductive surgery on survival of patients with low-grade serous ovarian carcinoma: A multicentric study of Turkish Society of Gynecologic Oncology (TRSGO-OvCa-001)Dogan Vatansever, Cagatay Taskiran, Mehmet Mutlu Meydanli, et al.Archives of Gynecology and Obstetrics|April 15, 2019
Prognostic factors and oncological outcomes of ovarian yolk sac tumors: a retrospective multicentric analysis of 99 casesGokhan Boyraz, Yasin Durmus, Irfan Cicin, et al.Journal of Clinical Medicine|June 12, 2026
Impact of Anatomical Localization on Systemic Inflammatory Markers and Immune Checkpoint CD47 in Desmoid TumorsSendag Yaslikaya, Suheda Atas Ipek, Ipek Balikci Cicek, et al.Medicina (Kaunas, Lithuania)|June 26, 2026
Dose-Adjusted EPOCH-R in Aggressive B-Cell Lymphomas: Efficacy, Molecular Prognostic Factors, and Real-World Outcomes from a Multicenter Turkish Cohort-A Turkish Oncology Group (TOG) StudyMehmet Mutlu Kidi, Hatice Asoglu, Metehan Soysal, et al.Balkan Medical Journal|March 16, 2019
Effect of Adjuvant Therapy on Oncologic Outcomes of Surgically Confirmed Stage I Uterine Carcinosarcoma: a Turkish Gynecologic Oncology StudyGünsu Kimyon Cömert, Osman Türkmen, Gökhan Boyraz, et al.Journal of Gynecologic Oncology|May 18, 2018
Impact of lymph node ratio on survival in stage IIIC endometrioid endometrial cancer: a Turkish Gynecologic Oncology Group studyAli Ayhan, Nazlı Topfedaisi Ozkan, Murat Öz, et al.Pageof 25